Michael Perkins Johnson - 13 Feb 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson
Issuer symbol
IDXX
Transactions as of
13 Feb 2025
Net transactions value
-$52,455
Form type
4
Filing time
18 Feb 2025, 21:43:18 UTC
Previous filing
16 Feb 2024
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +176 +76% $0.000000 406 14 Feb 2025 Direct F1
transaction IDXX Common Stock Options Exercise $0 +179 +44% $0.000000 585 14 Feb 2025 Direct
transaction IDXX Common Stock Tax liability $52,455 -118 -20% $444.53 467 14 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +3,657 $0.000000 3,657 13 Feb 2025 Common Stock 3,657 $459.76 Direct F2
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.000000 217 13 Feb 2025 Common Stock 217 $459.76 Direct F3
transaction IDXX Restricted Stock Unit Award $0 +870 $0.000000 870 13 Feb 2025 Common Stock 870 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -176 -33% $0.000000 352 14 Feb 2025 Common Stock 176 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -179 -25% $0.000000 535 14 Feb 2025 Common Stock 179 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 31, 2024 and December 31, 2024.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F4 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.